More tools:Markets·Screener·Research·Chat

PetMed Express, Inc. (PETS) Financial Statements

PetMed Express, Inc.
SIC 5912 · RETAIL-DRUG STORES AND PROPRIETARY STORES
FIGI BBG001S6TKF1
XNAS · usd
1.73▼ 0.03 (-1.76%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close1.76
Day's Range1.74 – 1.81
52-Week Range1.57 – 4.10
Volume64.0K
Avg Volume88.0K
Share Statistics
Shares Outstanding
Employees173
ExchangeXNAS
Listed1997-09-17
Share count as of August 7, 2026
Loading Income Statement…
Key questions about PetMed Express, Inc. (PETS)
What is PetMed Express, Inc.'s Market Cap?
PetMed Express, Inc.'s Market Cap is $37.5M, based on as-reported figures from SEC (XBRL) filings.
What is PetMed Express, Inc.'s Enterprise Value?
PetMed Express, Inc.'s Enterprise Value is $24.4M, based on as-reported figures from SEC (XBRL) filings.
What is PetMed Express, Inc.'s Price / Sales?
PetMed Express, Inc.'s Price / Sales is 0.2×, based on as-reported figures from SEC (XBRL) filings.
What is PetMed Express, Inc.'s EV / Revenue?
PetMed Express, Inc.'s EV / Revenue is 0.1×, based on as-reported figures from SEC (XBRL) filings.
What is PetMed Express, Inc.'s EV / EBITDA?
PetMed Express, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is PetMed Express, Inc.'s Revenue (TTM)?
PetMed Express, Inc.'s Revenue (TTM) is $168.9M, based on as-reported figures from SEC (XBRL) filings.
What is PetMed Express, Inc.'s Net Income (TTM)?
PetMed Express, Inc.'s Net Income (TTM) is -$29.3M, based on as-reported figures from SEC (XBRL) filings.
What is PetMed Express, Inc.'s EBITDA?
PetMed Express, Inc.'s EBITDA is -$21.5M, based on as-reported figures from SEC (XBRL) filings.
What is PetMed Express, Inc.'s Diluted EPS (TTM)?
PetMed Express, Inc.'s Diluted EPS (TTM) is -1.35, based on as-reported figures from SEC (XBRL) filings.
What is PetMed Express, Inc.'s EBITDA Margin?
PetMed Express, Inc.'s EBITDA Margin is -12.7%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Net sales
YoY growth-19.9%-15.6%-21.7%-23.6%
Cost of sales
Gross profit
% of revenue27.6%32.6%23.3%28.0%
Operating expenses:
General and administrative
Advertising
Depreciation and amortization
Impairment of goodwill and intangible assets
Total operating expenses
% of revenue42.8%45.9%49.0%46.9%
Loss from operations
% of revenue-15.2%-13.3%-25.7%-18.9%
Other income:
Interest (expense) income, net
Other, net
Total other income (expense)
Loss before provision for income taxes
Provision for income taxes
Net loss
% of revenue-15.0%-9.5%-26.0%-19.2%
Basic net loss per share (in dollars per share)
Diluted net loss per share (in dollars per share)